Report – Analysis of 2021 U.S FDA 483 GMP Observations
By
Barbara W. Unger
,
Areas examined in this report:
The total number of FDA form 483 observations in FY2021
Common themes from FDA 483 observations issued in FY2021
How these observations compare to previous years’ observations
If you have trouble with the form, please contact
events@redica.com
.
Access the white paper
If you have trouble with the form, please contact
events@redica.com
.